Hannah Lishman

Dr. Hannah Lishman

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2019 in BMJ
Verified
Journal Article
Open access
PDF file
MGMyriam Gharbi
Myriam Gharbi
JDJoseph H Drysdale
Joseph H Drysdale
HLHannah Lishman
Hannah Lishman
RGRosalind Goudie
Rosalind Goudie
MMMariam Molokhia
Mariam Molokhia
PAPaul Aylin
Paul Aylin
Objective: To evaluate the association between antibiotic treatment for urinary tract infection (UTI) and severe adverse outcomes in elderly patients in primary care.Design: Retrospective population based cohort study.Setting: Clinical Practice Research Datalink (2007-15) primary care records linked to hospital episode statistics and death records in England.Participants: 157 264 adults aged 65 years or older presenting to a general practitioner with at least one diagnosis of suspected or confirmed lower UTI from November 2007 to May 2015.Main outcome measures: Bloodstream infection, hospital admission, and all cause mortality within 60 days after the index UTI diagnosis.Results: Among 312 896 UTI episodes (157 264 unique patients), 7.2% (n=22 534) did not have a record of antibiotics being prescribed and 6.2% (n=19 292) showed a delay in antibiotic prescribing. 1539 episodes of bloodstream infection (0.5%) were recorded within 60 days after the initial UTI. The rate of bloodstream infection was significantly higher among those patients not prescribed an antibiotic (2.9%; n=647) and those recorded as revisiting the general practitioner within seven days of the initial consultation for an antibiotic prescription compared with those given a prescription for an antibiotic at the initial consultation (2.2%v0.2%; P=0.001). After adjustment for covariates, patients were significantly more likely to experience a bloodstream infection in the deferred antibiotics group (adjusted odds ratio 7.12, 95% confidence interval 6.22 to 8.14) and no antibiotics group (8.08, 7.12 to 9.16) compared with the immediate antibiotics group. The number needed to harm (NNH) for occurrence of bloodstream infection was lower (greater risk) for the no antibiotics group (NNH=37) than for the deferred antibiotics group (NNH=51) compared with the immediate antibiotics group. The rate of hospital admissions was about double among cases with no antibiotics (27.0%) and deferred antibiotics (26.8%) compared with those prescribed immediate antibiotics (14.8%; P=0.001). The risk of all cause mortality was significantly higher with deferred antibiotics and no antibiotics than with immediate antibiotics at any time during the 60 days follow-up (adjusted hazard ratio 1.16, 95% confidence interval 1.06 to 1.27 and 2.18, 2.04 to 2.33, respectively). Men older than 85 years were particularly at risk for both bloodstream infection and 60 day all cause mortality.Conclusions: In elderly patients with a diagnosis of UTI in primary care, no antibiotics and deferred antibiotics were associated with a significant increase in bloodstream infection and all cause mortality compared with immediate antibiotics. In the context of an increase ofEscherichia colibloodstream infections in England, early initiation of recommended first line antibiotics for UTI in the older population is advocated.

1 December 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
HLHannah Lishman
Hannah Lishman
CCCéire Costelloe
Céire Costelloe
SHSusan Hopkins
Susan Hopkins
AJAlan P. Johnson
Alan P. Johnson
RHRussell Hope
Russell Hope
PAPaul Aylin
Paul Aylin

4 April 2023 in BMJ Open
Verified
Journal Article
Open access
PDF file
HLHannah Lishman
Hannah Lishman
NNNathan C Nickel
Nathan C Nickel
HSHind Sbihi
Hind Sbihi
MXMax Xie
Max Xie
AMAbdullah Mamun
Abdullah Mamun
DPDavid M Patrick
David M Patrick
Introduction Allergic conditions, such as asthma, hay fever and eczema, are some of the most common conditions impacting children globally. There is a strong incentive to study their determinants to improve their prevention. Asthma, hay fever and eczema are influenced through the same immunological pathway and often copresent in children (‘the atopic march’). Increasing evidence shows a link between infant antibiotic use and the risk of childhood atopic conditions, mediated through gut microbial dysbiosis during immune system maturation, however, the potential for confounding remains. This study will investigate the relationship between infant antibiotic use and risk of allergic conditions in British Columbian and Manitoban children born over 10 years, adjusting for relevant confounders. Methods and analysis Provincial administrative datasets will be linked to perform comparable retrospective cohort analyses, using Population Data BC and the Manitoba Population Research Data Repository. All infants born between 2001 and 2011 in BC and Manitoba will be included (approximately 460 000 and 162 500 infants, respectively), following up to age 7. Multivariable logistic regression will determine the outcome risk by the fifth birthday among children who did and did not receive antibiotics before their first birthday. Clinical, demographic and environmental covariates will be explored, and sensitivity analyses performed to reduce confounding by indication. Ethics and dissemination The University of British Columbia Research Ethics Board (H19-03255) and University of Manitoba Ethics Board (HS25156 (H2021:328)) have approved this study. Data stewardship committees for all administrative datasets have granted permissions, facilitated by Population Data BC and the Manitoba Centre for Health Policy. Permissions from the Canadian Health Infant Longitudinal Development Study are being sought for breastfeeding data (CP185). Findings will be published in scientific journals and presented at infectious disease and respiratory health conferences. A stakeholder committee will guide and enhance sensitive and impactful communication of the findings to new parents.

11 December 2017 in Systematic Reviews
Verified
Journal Article
Open access
PDF file
HLHannah Lishman
Hannah Lishman
PAPaul Aylin
Paul Aylin
VAVivian Alividza
Vivian Alividza
ECEnrique Castro-Sánchez
Enrique Castro-Sánchez
ACAnuja Chatterjee
Anuja Chatterjee
CCCéire Costelloe
Céire Costelloe
Antibiotic resistance (ABR) is an urgent problem globally, with overuse and misuse of antibiotics being one of the main drivers of antibiotic-resistant infections. There is increasing evidence that the burden of community-acquired infections such as urinary tract infections and bloodstream infections (both susceptible and resistant) may differ by ethnicity, although the reasons behind this relationship are not well defined. It has been demonstrated that socioeconomic status and ethnicity are often highly correlated with each other; however, it is not yet known whether accounting for deprivation completely explains any discrepancy seen in infection risk. There have currently been no systematic reviews summarising the evidence for the relationship between ethnicity and antibiotic resistance or prescribing. This protocol will outline how we will conduct this systematic literature review and meta-analysis investigating whether there is an association between patient ethnicity and (1) risk of antibiotic-resistant infections or (2) levels of antibiotic prescribing in high-income countries. We will search PubMed/MEDLINE, EMBASE, Global Health, Scopus and CINAHL using MESH terms where applicable. Two reviewers will conduct title/abstract screening, data extraction and quality assessment independently. The Critical Appraisal Skills Programme (CASP) checklist will be used for cohort and case-control studies, and the Cochrane collaboration’s risk of bias tool will be used for randomised control trials, if they are included. Meta-analyses will be performed by calculating the minority ethnic group to majority ethnic group odds ratios or risk ratios for each study and presenting an overall pooled odds ratio for the two outcomes. The Grading of Recommendations, Assessments, Development and Evaluation (GRADE) approach will be used to assess the overall quality of the body of evidence. In this systematic review and meta-analysis, we will aim to collate the available evidence of whether there is a difference in rates of AMR and/or antibiotic prescribing in minority vs. majority ethnic groups in high-income countries. Additionally, this review will highlight areas where more research needs to be conducted and may provide insight into what may cause differences in this relationship, should they be seen. PROSPERO ( CRD42016051533 )

6 September 2016 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
VVVenanzio Vella
Venanzio Vella
PAPaul P Aylin
Paul P Aylin
LMLuke S. P. Moore
Luke S. P. Moore
AKAlice King
Alice King
NNNichola R Naylor
Nichola R Naylor
AHAlison Holmes
Alison Holmes
Background: The study aimed to identify thresholds for hospital bed utilisation which are independently associated with significantly higher risks for Clostridium difficile infections (CDI) in acute hospitals in England. Method: A retrospective analysis was carried out on reported data from the English National Health Service (NHS) for the financial year 2013/2014. Reported rates of CDI were used as a proxy for hospital infection rates in acute NHS hospital trusts. Multivariate linear regression was used to assess the relationship between bed utilisation values and CDI controlling for confounding factors. Hospitals were finally plotted in a Pabon Lasso graph according to their average bed occupancy rate (BOR) and bed turnover rate (BTR) per year to visualise the relationship between bed utilisation and CDI. Results: Among English hospital NHS trusts, increasing BTR and decreasing BOR were associated with a decrease in CDI. However, this effect was not large, and patient mix had a larger impact on CDI rates than bed utilisation. Conclusions: While policymakers and managers wishing to target healthcare providers with high CDI rates should look at bed utilisation measures, focusing on these alone is unlikely to have the desired impact. Instead, strategies to combat CDI must take a wider perspective on contributory factors at the institutional level.

18 November 2024 in The Journal of the American Dental Association
Verified
Journal Article
Closed access
SSSäde Stenlund
Säde Stenlund
JHJeremy Huynh
Jeremy Huynh
CPClifford Pau
Clifford Pau
ECErica Chuang
Erica Chuang
HLHannah Lishman
Hannah Lishman
DPDavid M. Patrick
David M. Patrick